SPECT imaging and biodistribution studies of 111In-EGF-Au-PEG nanoparticles in vivo
Radiolabelled antibodies and peptides hold promise for molecular radiotherapy but are often limited by low payload resulting in delivery of inadequate amounts of radioactivity to tumour tissue and, therefore, modest therapeutic effect. We have developed PEGylated epidermal growth factor (EGF)-gold n...
Main Authors: | Song, L, Able, S, Falzone, N, Kersemans, V, Vallis, K |
---|---|
Format: | Conference item |
Published: |
SpringerOpen
2016
|
Similar Items
-
Accumulation of 111In-Labelled EGF-Au-PEG Nanoparticles in EGFR-Positive Tumours is Enhanced by Co-administration of Targeting Ligand
by: Song, L, et al.
Published: (2017) -
Nanographene oxide-based radioimmunoconstructs for in vivo targeting and SPECT imaging of HER2-positive tumors.
by: Cornelissen, B, et al.
Published: (2013) -
EGF-coated gold nanoparticles provide an efficient nano-scale delivery system for the molecular radiotherapy of EGFR-positive cancer.
by: Song, L, et al.
Published: (2016) -
A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer.
by: Reilly, R, et al.
Published: (2000) -
Development of 111In-labeled porphyrins for SPECT imaging
by: Shaghayegh Sadeghi, et al.
Published: (2014-10-01)